Glembatumumab (Anti-GPNMB)
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.
Catalog Number | A2475 |
CAS# | 1020264-78-1 |
Size | 1mg*5 |
Supplier Page | http://www.selleckchem.com/products/glembatumumab-anti-gpnmb.html |